Bethan Powell

3.8k total citations · 2 hit papers
10 papers, 2.9k citations indexed

About

Bethan Powell is a scholar working on Genetics, Reproductive Medicine and Cancer Research. According to data from OpenAlex, Bethan Powell has authored 10 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 5 papers in Reproductive Medicine and 4 papers in Cancer Research. Recurrent topics in Bethan Powell's work include Ovarian cancer diagnosis and treatment (5 papers), BRCA gene mutations in cancer (4 papers) and Endometrial and Cervical Cancer Treatments (2 papers). Bethan Powell is often cited by papers focused on Ovarian cancer diagnosis and treatment (5 papers), BRCA gene mutations in cancer (4 papers) and Endometrial and Cervical Cancer Treatments (2 papers). Bethan Powell collaborates with scholars based in United States, United Kingdom and Australia. Bethan Powell's co-authors include James Carmichael, Mark Wickens, Richard T. Penson, M. William Audeh, Andrew Tutt, Katherine M. Bell‐McGuinn, Niklas Loman, Clare L. Scott, Karen H. Lu and Ursula A. Matulonis and has published in prestigious journals such as The Lancet, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Bethan Powell

10 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

2010 1.7k citations M. William Audeh, James Carmichael et al. The Lancet profile →
PIK3CA is implicated as an oncogene in ovarian cancer

1999 925 citations Yiling Lu, Wen-Lin Kuo et al. Nature Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bethan Powell United States	6	1.8k	1.6k	708	663	594	10	2.9k
Rebecca Kristeleit United Kingdom	27	1.4k 0.8×	1.6k 1.0×	299 0.4×	711 1.1×	400 0.7×	147	2.9k
Rita K. Schmutzler Germany	22	2.5k 1.4×	2.7k 1.6×	1.3k 1.9×	488 0.7×	917 1.5×	49	4.1k
Rita K. Schmutzler Germany	19	1.2k 0.6×	1.4k 0.9×	695 1.0×	506 0.8×	618 1.0×	65	2.4k
David S. Boss Netherlands	14	2.5k 1.4×	3.1k 1.9×	939 1.3×	713 1.1×	778 1.3×	24	4.4k
Ingunn M. Stefansson Norway	36	2.2k 1.2×	1.5k 0.9×	470 0.7×	625 0.9×	1.3k 2.2×	73	4.4k
Rachel Brough United Kingdom	21	2.4k 1.3×	2.1k 1.3×	480 0.7×	288 0.4×	448 0.8×	39	3.1k
Darren Hodgson United Kingdom	21	1.4k 0.8×	2.3k 1.4×	704 1.0×	925 1.4×	498 0.8×	73	3.1k
Damian A. Johnson United Kingdom	4	3.5k 2.0×	3.6k 2.2×	874 1.2×	454 0.7×	802 1.4×	4	4.9k
J.G.M. Klijn Netherlands	26	1.1k 0.6×	1.5k 0.9×	1.2k 1.7×	275 0.4×	1.4k 2.4×	67	3.3k
Kirsten M. Timms United States	27	2.2k 1.2×	2.6k 1.6×	1.5k 2.1×	681 1.0×	1.2k 2.0×	96	4.6k

Countries citing papers authored by Bethan Powell

Since Specialization

Citations

This map shows the geographic impact of Bethan Powell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bethan Powell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bethan Powell more than expected).

Fields of papers citing papers by Bethan Powell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bethan Powell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bethan Powell. The network helps show where Bethan Powell may publish in the future.

Co-authorship network of co-authors of Bethan Powell

This figure shows the co-authorship network connecting the top 25 collaborators of Bethan Powell. A scholar is included among the top collaborators of Bethan Powell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bethan Powell. Bethan Powell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Razieh, Cameron, Bethan Powell, Isobel Ward, et al.. (2025). Understanding the quality of ethnicity data recorded in health-related administrative data sources compared with Census 2021 in England. PLoS Medicine. 22(2). e1004507–e1004507. 1 indexed citations

2.

Armstrong, Mary Anne, et al.. (2020). Variation in physician-directed immunohistochemistry screening among women with endometrial cancer. International Journal of Gynecological Cancer. 30(9). 1356–1365. 4 indexed citations

3.

Clarke, Christina L., Lawrence H. Kushi, Jessica Chubak, et al.. (2019). Predictors of Long-Term Survival among High-Grade Serous Ovarian Cancer Patients. Cancer Epidemiology Biomarkers & Prevention. 28(5). 996–999. 17 indexed citations

4.

Bandera, Elisa V., Valerie Lee, Bo Qin, et al.. (2017). Abstract 5323: Obesity and ovarian cancer survival revisited. Cancer Research. 77(13_Supplement). 5323–5323. 1 indexed citations

5.

Chapman, Jocelyn, et al.. (2016). Comparing Coordinated Versus Sequential Salpingo-Oophorectomy for BRCA1 and BRCA2 Mutation Carriers With Breast Cancer. Clinical Breast Cancer. 16(6). 494–499. 8 indexed citations

6.

Rafii, Saeed, Charlie Gourley, Joo Ern Ang, et al.. (2015). What clinical factors influence advanced BRCA1/2 mutant ovarian cancer patient (BMOC pt) outcomes to poly(ADP-ribose) polymerase inhibitor (PARPi) treatment?. Journal of Clinical Oncology. 33(15_suppl). 5546–5546. 1 indexed citations

7.

Audeh, M. William, James Carmichael, Richard T. Penson, et al.. (2010). Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial. The Lancet. 376(9737). 245–251. 1742 indexed citations breakdown →

8.

Qayyum, Aliya, et al.. (2004). Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer. Gynecologic Oncology. 96(2). 301–306. 144 indexed citations

9.

Suzuki, Seiji, Dan H. Moore, David G. Ginzinger, et al.. (2000). An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer.. PubMed. 60(19). 5382–5. 98 indexed citations

10.

Lu, Yiling, Wen-Lin Kuo, R. A. Baldocchi, et al.. (1999). PIK3CA is implicated as an oncogene in ovarian cancer. Nature Genetics. 21(1). 99–102. 925 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact